<DOC>
	<DOCNO>NCT01326689</DOCNO>
	<brief_summary>This placebo-controlled , double blind , comparative study evaluate efficacy safety KW-2246 rescue medication optimal dose , determine dose titration treat breakthrough pain episode adult cancer patient receive strong opioid analgesic fixed-schedule well rescue medication breakthrough pain .</brief_summary>
	<brief_title>A Comparative Study KW-2246</brief_title>
	<detailed_description />
	<mesh_term>Breakthrough Pain</mesh_term>
	<criteria>Written inform consent Have treat opioid analgesic fixedschedule stable daily dose Receiving least 1 4 dos rescue medication per day average whose pain control ECOG PS = &lt; 3 Currently suffer intolerable opioidspecific adverse reaction due opioid analgesic Severe respiratory dysfunction Asthma Severe bradyarrhythmia Severe hepatic function disorder Severe renal function disorder Severe psychoneurotic disorder Susceptibility respiratory depression due condition increase intracranial pressure , head injury brain tumor</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>